Back to results
CompletedPhase 2

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

NCT00134680

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Lombardi Cancer Institute, Georgetown University Medical Center

Washington D.C., District of Columbia, United States

+3 additional locations

View on ClinicalTrials.gov
Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC — TrialFind